Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pain Therapeutics Inc.
DescriptionAbuse-resistant opioid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today